Neurologiske bivirkninger af cancerimmunterapi med checkpointinhibitorer
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 1.13 MB, PDF document
Treatment with checkpoint inhibitors has revolutionised the treatment of many different cancers with a significant improvement in cancer survival. However, a different type of adverse effects is seen compared to standard chemotherapy called immune-related adverse effects (irAE). In this review, we give recommendations on how to diagnose and treat the most common and severe neurologic irAE. We advise clinicians to be cautious to classify neurologic irAE as well-known nosologic entities, since their presentation, cause and treatment often is different.
Translated title of the contribution | Neurological adverse effects of cancer therapy with checkpoint inhibitors |
---|---|
Original language | Danish |
Article number | V05200406 |
Journal | Ugeskrift for Laeger |
Volume | 183 |
Issue number | 2 |
Number of pages | 9 |
ISSN | 0041-5782 |
Publication status | Published - 11 Jan 2021 |
Links
ID: 288283903